/ Unknown statusPhase 1IIT A Randomized, Double-blind, Placebo-controlled, Single-dose, Dose-escalation Study to Evaluate the Tolerance and Pharmacokinetics of Suramin Sodium in Healthy Chinese Adults
This is a randomized, double-blind, placebo-controlled, single-dose with three incremental doses, Phase 1 study to evaluate the tolerance and pharmacokinetics of suramin sodium for injection in Chinese healthy adults.
100 Clinical Results associated with Guangdong Kangda Pharmaceutical Co. Ltd.
0 Patents (Medical) associated with Guangdong Kangda Pharmaceutical Co. Ltd.
100 Deals associated with Guangdong Kangda Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Guangdong Kangda Pharmaceutical Co. Ltd.